Skip to search formSkip to main contentSkip to account menu

ZK-EPO

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ZK-Epothilonesagopilone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate
Background: Tubulin is among the most established and clinically validated targets in oncology. The taxanes, paclitaxel and… 
2008
2008
Phase II study of sagopilone (ZK-EPO) plus prednisone as first-line chemotherapy in patients with metastatic androgen-independent prostate cancer (AIPC)
5141 Background: The microtubule stabilizer docetaxel, in combination with prednisone, prolongs life in patients with metastatic… 
2008
2008
Phase I trial of the novel epothilone sagopilone (ZK-EPO) in combination with cisplatin as first-line therapy in patients with extensive-disease small-cell lung cancer (ED-SCLC)
19081 Background: Sagopilone, a novel epothilone, has shown preclinical activity against SCLC cell lines. A completed Phase I… 
2008
2008
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)